glp-1 neuroendocrine tumor Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Risk of pancreatic cancer associated

L.Casado-DazA.et al (2020)

The presence of other substances can influence the outcomes of L-carnitine, making it difficult to assess its role in isolation

Despite promising preclinical data, clinical trials in humans are extremely limited, and the compound remains largely experimental, with ongoing research required to fully characterize pharmacokinetics, optimal dosing, long-term safety, and potential off-target effects.

The specific mechanisms remain under investigation, but the finding adds another dimension to DSIP's systemic regulatory effects

Many patients begin to see improvement within a few months, although the exact timeline varies